Nektar Therapeutics Market Cap

Nektar Therapeutics has a market cap or net worth of $751.01 million as of January 21, 2026. Its market cap has increased by 323.58% in one year.

Market Cap

751.01M

Enterprise Value

647.88M

1-Year Change

323.58%

Ranking

#2797

Market Cap Chart

Since December 1, 1998, Nektar Therapeutics's market cap has increased from $478.60M to $751.01M, an increase of 56.92%. That is a compound annual growth rate of 1.67%.

Market Cap History

Date	Market Cap	% Change
Jan 20, 2026	737.00M	-14.30%
Dec 31, 2025	860.00M	401.46%
Dec 31, 2024	171.50M	59.09%
Dec 29, 2023	107.80M	-74.62%
Dec 30, 2022	424.80M	-82.96%
Dec 31, 2021	2.49B	-18.24%
Dec 31, 2020	3.05B	-19.69%
Dec 31, 2019	3.80B	-33.26%
Dec 31, 2018	5.69B	-39.50%
Dec 29, 2017	9.40B	401.47%
Dec 30, 2016	1.88B	-16.61%
Dec 31, 2015	2.25B	12.95%
Dec 31, 2014	1.99B	51.06%
Dec 31, 2013	1.32B	54.43%
Dec 31, 2012	853.40M	33.30%
Dec 30, 2011	640.20M	-47.19%
Dec 31, 2010	1.21B	39.56%
Dec 31, 2009	868.60M	68.99%
Dec 31, 2008	514.00M	-16.91%
Dec 31, 2007	618.60M	-54.96%
Dec 29, 2006	1.37B	-4.78%
Dec 30, 2005	1.44B	-15.13%
Dec 31, 2004	1.70B	122.51%
Dec 31, 2003	763.80M	70.57%
Dec 31, 2002	447.80M	-56.04%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Arbutus Biopharma	796.22M
MiMedx Group	789.38M
SELLAS Life Sciences Group	779.89M
REGENXBIO	760.36M
Kura Oncology	758.79M
Gyre Therapeutics	754.39M
MapLight Therapeutics	739.72M
NovaBay Pharmaceuticals	739.68M

Market Cap Rankings